News and Trends 12 Aug 2021
European Biotechs Fire up Deals to Develop Parkinson’s Treatments
Last month, European biotechs Ipsen and AC Immune announced multi-million euro deals to acquire or license treatments for Parkinson's disease.…
Ipsen
- Latest Posts
News and Trends 31 Mar 2020
Ipsen Resumes Phase III Testing for Rare Disease Drug and Abandons Pediatric Trial
The French pharmaceutical company Ipsen has restarted the dosing of its treatment for a rare bone disease in a phase…
News and Trends 8 Jun 2016
12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting
Pharma and Biotech from every corner flocked to Chicago for the beginning of June. Why? It's where one of the…
News and Trends 1 Mar 2016
French Ipsen closes €700M deal for Californian Cancer Drug
Ipsen is paying Exelixis $200M upfront, plus $545M in future milestones to acquire commercialization rights for a multi-organ cancer candidate…
ADVERTISEMENT
News and Trends 2 Jun 2015
After Failing Phase III, Active Biotech is back to square one
Unfortunately, the Biotech world is not only composed of success stories. Active Biotech, a Swedish company focused on developing treatments for neurodegenerative…
News and Trends 25 Feb 2015
Ipsen buys an option to Acquire Canbex
Canbex, a spin-off of University College London (UCL) that raised a Series A financing of €2.8M in 2013 from MS…